EUCTR2004-001331-36-IT进行中（未招募）1 期
A randomized phase III study of follow-up with or without Gefitinib (IressaTM) following chemotherapy in patients with advanced non-small cell lung cancer.
IST. DI RICERCHE FARMACOLOG. M. NEGRI0 个研究点目标入组 0 人开始时间: 2005年2月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A randomized phase III study of follow up with or without adjuvant Gefitinib(IressaTM) following chemotherapy in patients with advanced non-small cell lungcancerAdvanced Non Small Cell Lung CarcinomaMedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2004-001331-36-GBEuropean Organisation for Research and Treatment of Cancer
已完成
不适用
A randomized phase III study in previously untreated patients with biological high-risk CLL: fludarabine and cyclophosphamide (FC) versus FC and low-dose alemtuzumabCancerLeukaemiaISRCTN25180151Rigshospitalet (Denmark)300
进行中（未招募）
1 期
A randomized phase III study in previously untreated patients with biological high-risk CLL: Fludarabine + cyclophosphamide (FC) versus FC + low-dose alemtuzumabEUCTR2005-000309-75-CZHOVON CLL Group300
进行中（未招募）
1 期
A randomized phase III study of standard treatment +/- enoxaparin in small cell lung cancer.Patients with small cell lung cancer, who are going to receive chemotherapy treatment with a platinum- and topoisomeras inhibitor containing regimen.MedDRA version: 14.1Level: LLTClassification code 10041067Term: Small cell lung cancerSystem Organ Class: 100000004864EUCTR2007-006033-14-SEniversity Hospital Lund, Thoracic Oncology Unit, Dept of Respiratory Medicine390
进行中（未招募）
1 期
A randomized phase III study of standard treatment +/- enoxaparin in small cell lung cancer.Patients with small cell lung cancer, who are going to receive chemotherapy treatment with a platinum- and topoisomeras inhibitor containing regimen.MedDRA version: 17.0Level: PTClassification code 10041067Term: Small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-006033-14-DKniversity Hospital Lund, Thoracic Oncology Unit, Dept of Respiratory Medicine390